The US Epilepsy Monitoring Devices market demonstrated solid revenue growth, with the market size standing at 890 million in 2021 and projected to reach 2,230 million by 2035. The industry is benefiting from increasing epilepsy diagnoses, continuous product innovations, and policy support for technology adoption across care settings. The growth trajectory underscores the shift from hospital-based to home and ambulatory monitoring, reflecting evolving patient needs and payer incentives.
Read More - https://bussinessinsights.com/research-report/us-epilepsy-monitoring-devices
Hospitals are the leading application segment for epilepsy monitoring devices in the US for 2025, signifying the critical need for diagnostics and treatment within inpatient settings. Home care settings are becoming increasingly important as device usability and patient autonomy rise. Clinics and diagnostic centers follow, fulfilling demands for outpatient care and specialized epilepsy evaluations. The surge in specialty centers and research institutes underscores a focus on precision medicine and advancing epilepsy management.
Request Free Sample- https://bussinessinsights.com/request/medical-devices/us-epilepsy-monitoring-devices
Who are the key players in US Epilepsy Monitoring Devices industry?
The top 5 players in the US Epilepsy Monitoring Devices market are Nihon Kohden, Natus Medical, Compumedics, Cadwell Industries, and Medtronic. These companies lead the market through advanced neurodiagnostic technologies, wide product portfolios, and strong distribution networks, making them major contributors to innovation and growth in the industry.
What is the US Epilepsy Monitoring Devices growth?
The US Epilepsy Monitoring Devices market has shown robust growth in recent years, driven by technological advancements and increasing awareness. For example, Nihon Kohden reported strong revenue growth in 2023 due to rising demand for advanced EEG and long-term monitoring solutions in hospitals and clinics.
Which segment accounted for the largest US Epilepsy Monitoring Devices share?
In the US, the largest market share is held by the hospitals and clinics segment. This is due to their high adoption of inpatient and long-term epilepsy monitoring units, which provide comprehensive patient assessment and diagnostic capabilities, resulting in increased utilization of epilepsy monitoring devices.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com